Efficacy of Telavancin in the Treatment of Experimental Endocarditis Due to Glycopeptide-Intermediate Staphylococcus aureus

The efficacy of telavancin, a novel lipoglycopeptide, was evaluated in experimental endocarditis in rabbits using two clinical isolates of glycopeptide-intermediate Staphylococcus aureus: ATCC 700788 and HIP 5836. Infected rabbits were treated for 2 days with telavancin (10 mg/kg of body weight once...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Miró, José M., García-de-la-Mària, Cristina, Armero, Yolanda, de-Lazzari, Elisa, Soy, Dolors, Moreno, Asunción, del Rio, Ana, Almela, Manel, Mestres, Carlos A., Gatell, José M., Jiménez-de-Anta, María-Teresa, Marco, Francesc
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2007
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1913277/
https://ncbi.nlm.nih.gov/pubmed/17485502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01266-06
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados